Current Drug Targets

Francis J. Castellino
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
USA

Back

Editorial (Hot Topic: The First Theme Issue on PPARs for Brain Disorders) promotion: free to download

Volume:14   Issue:7
Pp: 723-723
Regis Bordet and Benjamin Rolland
DOI: 10.2174/1389450111314070001

Order Reprints Order Eprints

Therapeutic Prospects of PPARs in Psychiatric Disorders: A Comprehensive Review

Volume:14   Issue:7
Pp: 724-732
Benjamin Rolland, Julie Deguil, Renaud Jardri, Olivier Cottencin, Pierre Thomas and Regis Bordet
DOI: 10.2174/1389450111314070002

Order Reprints Order Eprints

Targeting PPAR Isoforms Following CNS Injury

Volume:14   Issue:7
Pp: 733-742
Heather M. Yonutas and Patrick G. Sullivan
DOI: 10.2174/1389450111314070003

Order Reprints Order Eprints

PPARs: A Potential Target for a Disease-Modifying Strategy in Stroke

Volume:14   Issue:7
Pp: 752-767
Thavarak Ouk, Camille Potey, Sophie Gautier, Michele Bastide, Dominique Deplanque, Bart Staels, Patrick Duriez, Didier Leys and Regis Bordet
DOI: 10.2174/1389450111314070005

Order Reprints Order Eprints

Peroxisome Proliferator-Activated Receptor (PPAR) Agonists as Promising New Medications for Drug Addiction: Preclinical Evidence

Volume:14   Issue:7
Pp: 768-776
Bernard Le Foll, Patricia Di Ciano, Leigh V. Panlilio, Steven R. Goldberg and Roberto Ciccocioppo
DOI: 10.2174/1389450111314070006

Order Reprints Order Eprints

Cyclization in Opioid Peptides

Volume:14   Issue:7
Pp: 798-816
Justyna Piekielna, Renata Perlikowska, Katarzyna Gach and Anna Janecka
DOI: 10.2174/1389450111314070008

Order Reprints Order Eprints